IDEAYA Biosciences, Inc.
IDYA
$25.00
$0.140.56%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -77.49M | -72.18M | -130.31M | -51.82M | -52.77M |
Total Depreciation and Amortization | 1.23M | 1.13M | 643.00K | 1.01M | 1.10M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 9.18M | 6.46M | 4.57M | 3.85M | 3.09M |
Change in Net Operating Assets | 4.61M | 4.24M | 3.45M | -2.28M | 15.70M |
Cash from Operations | -62.47M | -60.34M | -121.66M | -49.23M | -32.88M |
Capital Expenditure | -663.00K | -1.33M | -1.10M | -457.00K | -973.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 46.58M | 81.15M | -196.01M | -19.58M | 69.53M |
Cash from Investing | 45.92M | 79.82M | -197.11M | -20.04M | 68.56M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 1.21M | 26.14M | 2.75M | 277.10M | 39.18M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 0.00 | 9.40M | -- |
Cash from Financing | 1.21M | 26.14M | 2.75M | 286.50M | 39.18M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -15.35M | 45.62M | -316.01M | 217.23M | 74.86M |